Mashup Score:24
STATMD Anderson hit with ethics complaint over undisclosed clinical trial results - 2 days
Mashup Score:24
# cancer
Mashup Score:7
Medical XpressImagine you’re about to go on a cross-country trip, stopping at spots along the way to admire local attractions. You’d probably want to have...
-
Molecular atlas of small cell lung #cancer reveals unusual cell type that could explain why it's so aggressive @sloan_kettering https://t.co/cZvW2C5Yo9 - view on twitter
More coverage:
#cancer
Mashup Score:4
ascopost.comAdjuvant pembrolizumab reduced the risk of recurrence in adults and children older than age 12 with high-risk stage II (AJCC 8th edition, stage IIB/IIC)...
-
Adjuvant Pembrolizumab Shows Efficacy in High-Risk Stage II Melanoma in Adults and Children Older Than 12 https://t.co/83XiOWI6th #melsm #oncology #cancer #immunotherapy #ESMO21 - view on twitter
Mashup Score:3
ascopost.comBy The ASCO Post Staff Posted: 10/14/2021 11:13:00 AM Last Updated: 10/14/2021 10:53:17 AM On October 13, the U.S. Food and Drug Administration (FDA)...
-
.@US_FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer https://t.co/9t6MwAn2Ta #gyncsm #oncology #cancer @FDAOncology - view on twitter
Mashup Score:2
ascopost.comFDA Approves Atezolizumab as Adjuvant Treatment for NSCLC – The ASCO Post - 21 hours
Mashup Score:2
By The ASCO Post Staff Posted: 10/15/2021 12:49:00 PM Last Updated: 10/15/2021 12:12:41 PM On October 15, the U.S. Food and Drug Administration (FDA)...
-
.@US_FDA Approves Atezolizumab as Adjuvant Treatment for NSCLC https://t.co/hOMEgcWkQ3 #LCSM #oncology #cancer @FDAOncology - view on twitter
Mashup Score:1
ascopost.comBy Jo Cavallo Posted: 10/14/2021 1:12:00 PM Last Updated: 10/14/2021 1:16:51 PM The AACR Cancer Progress Report 2021 celebrates the gains made in cancer...
-
.@AACR Cancer Progress Report 2021 Showcases 50 Years of Advances in Cancer Research and Treatment https://t.co/lLAKTApH73 #cancer - view on twitter
More coverage:
#cancer
Mashup Score:1
PLOSAuthor summary GFI1 is a key transcriptional repressor in hematopoiesis. The E3 ubiquitin ligase targeting GFI1 for proteasomal degradation remains obscure for many years....
-
What role does the ring finger protein Irf2bp2a play in #Cancer? Gao et al show that Irf2bp2a targets GFI1 for proteasomal degradation, with different levels of GFI1 acting as a tumor suppressor or an oncogene #CancerResearch 🔎 Learn more: https://t.co/K4WFURqXO8 https://t.co/K4WFURqXO8 - view on twitter
Mashup Score:1
Oncology TubePodcast – Eric Klein, MD @EricKleinMD @ClevelandClinic - 2 days
Mashup Score:1
Eric Klein, MD from the Glickman Urological and Kidney Institute at the Cleveland Clinic speaks about the AUA 2021 Abstract – MP60-03 ISOPSA: CLINICAL...
-
Podcast - ISOPSA: Clinical Performance Of A Single Parameter, Structure Based Test For High Grade Prostate Cancer Eric Klein, MD @EricKleinMD @ClevelandClinic #AUA21 #ISOPSA #ProstateCancer #Cancer #Research Link to Audio: https://t.co/pwroW4q2Ro...?channelName=MyOncologyTube https://t.co/pwroW4q2Ro...?channelName=MyOncologyTube - view on twitter
Mashup Score:1
lww.comWolters Kluwer Health - 2 days
Mashup Score:1
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers:...
-
#TBT: Understanding Tolerance for Imatinib Nonadherence Among CML Patients https://t.co/HgGQs7IUJu #leusm #cancer #medtwitter via @AzHEOR @uarizona https://t.co/HgGQs7IUJu - view on twitter
Eric Klein, MD from the Glickman Urological and Kidney Institute at the Cleveland Clinic speaks about the AUA 2021 Abstract – MP60-03 ISOPSA: CLINICAL...
-
ISOPSA: Clinical Performance Of A Single Parameter, Structure Based Test For High Grade Prostate Cancer Eric Klein, MD @EricKleinMD @ClevelandClinic #AUA21 #ISOPSA #ProstateCancer #Cancer #Research https://t.co/7F47K5RLyl...?channelName=MyOncologyTube https://t.co/7F47K5RLyl...?channelName=MyOncologyTube - view on twitter
“This is an ideal test case for transparency because it is so extreme,” said Till Bruckner of TransariMed, an advocacy...
MD Anderson hit with ethics complaint over failure to disclose clinical trial results.. read why here.. https://t.co/9pFrs06wjg #pharma #biotech #transparency #clinicaltrials #braintumor #cancer - view on twitter